AMB Express has launched In Review, a new option that provides authors with on-demand information on the status of their manuscript, enables them to share their work with funders and their research community, and allows their colleagues to comment and collaborate - all whilst their manuscript is under review.
Featured article - Numaswitch: an efficient high-titer expression platform to produce peptides and small proteins
Peptides represent a class of active pharmaceutical ingredients (API) with rapidly increasing importance. Several factors limit a broader commercial application of peptides. This study shows the application of Numaswitch, a new technology which can solve the problem of reliably producing diverse peptides and small proteins varying in length, physicochemical and functional characteristics.
Announcing the launch of In Review
Mini-reviews are summaries of recent insights or advances in specific research areas. This collection features all the mini-reviews published in AMB Express and provides a great account of important issues in the field of applied and industrial microbiology.
Aims and scope
AMB Express is a high quality journal that brings together research in the area of Applied and Industrial Microbiology with a particular interest in 'White Biotechnology' and 'Red Biotechnology'. The emphasis is on processes employing microorganisms, eukaryotic cell cultures or enzymes for the biosynthesis, transformation and degradation of compounds. This includes fine and bulk chemicals, polymeric compounds and enzymes or other proteins. Downstream processes are also considered. Integrated processes combining biochemical and chemical processes are also published.
Reports on the use of new procedures or tools in a clinical setting are only considered for publication if microorganisms, viruses, enzymes or other proteins from microorganisms or metabolites of microorganisms are involved as crucial and central part of the new procedure or tool.
The high quality journal, AMB Express, was founded as a fully open access sister journal to Applied Microbiology and Technology about 6 years ago. Since then, the journal has become well-known to authors and reviewers whilst steadily growing. This year, we already have more than 400,000 downloads. Meanwhile, AMB Express has had several achievements: following indexing by ISI, it has since received two consecutive Thomson Reuters Science Citation Index Impact Factors. These Impact Factors were unexpectedly high, and we are very confident that they will continue to grow. What is, however, most important is that not only the number of manuscripts is increasing, but also their volume and the quality of their contents. The editors of AMB Express, the managing editor and I, will ensure that the journal’s performance and the quality of the published papers will continue to improve and that more excellent and highly cited papers will be published in AMB Express. Papers devoted to ‘Industrial Microbiology’ and with a particular interest in ‘White and Red Biotechnology’ are highly welcome; this also includes short papers in which important achievements are communicated.
Alexander Steinbüchel, Editor-in-Chief
University of Münster
Annual Journal Metrics
50 days to first decision for reviewed manuscripts only
32 days to first decision for all manuscripts
72 days from submission to acceptance
12 days from acceptance to publication
- ISSN: 2191-0855 (electronic)